Search Results
Edit Save
20,729,885 results
You did not enter any search terms or parameters. Please go to the advanced search form and try again.
Kukmin Ilbo (Korea) 05/19/2019 20:01
배우 서강준이 일본에서 뜨거운 인기를 과시했다. 서강준은 지난 18일과 19일에 걸쳐 일본 팬들과 뜻깊은 시간을 함께하며 팬들의 변함없는 사랑을 확인했다. 먼저 서강준은 18일 도쿄 요미우리홀에서 열린 ‘KBS World Presents 서강준 Special Event'을 통해 팬들을 만났다. 무엇보다 2회차 공연 전석이 매진된 이번 공연은 서강준에 대한 팬들의 애정과 관심을 확인한 가운데 한류 스타로서의 저력을 입증했다. 직접 부른 드라마 '너도 인간이니’의 OST 'You are my Love'로 팬미팅의 포문을 연 서강준은 일본에서 방송된 ‘너도 인간이니’, ‘제 3의 매력’등의 하이라이트 영상 보며 에피소드를 풀어 놓았다. 이후 관객석으로 직접 찾아가 팬들의 궁금증에 직접 대답을 해주는가 하면, 추첨을 통해 당첨된 팬들과는 함께 연기하며 설레임을 선사하기도. 이번 팬미팅에서 가장 눈에 띄는 것은 일본어로 일본 팬들과 직접 소통하는 서강준의 모습이었다. 최근 일본어를 배우고 있다고 밝힌 서강준은 팬들을 위해서 일본어를 배우고 싶었다고 밝혀 팬들에게 감동을 안겼다. 이 가운데 배우 공명과 이태환이 서프라이즈 게스트로 참석해 팬미팅을 더욱 풍성하게 채워 눈길을 끌었다. 공명과 이태환의 능청스러움이 가미된 재치 넘치는 무대매너는 팬미팅에 유쾌함을 더했고, 세 사람의 남다른 케미는 분위기를 더욱 친밀하고 다정하게 만들며 팬미팅의 열기를 고조시켰다. 또한, 서강준의 노래는 관객들의 귀를 사로잡았다. 오프닝 곡 'You are.
insideBIGDATA 05/19/2019 20:00
ACM, the Association for Computing Machinery, announced that Chelsea Finn receives the 2018 ACM Doctoral Dissertation Award for her dissertation, “Learning to Learn with Gradients.” In her thesis, Finn introduced algorithms for meta-learning that enable deep networks to solve new tasks from small data sets, and demonstrated how her algorithms can be applied in areas including computer vision, reinforcement learning and robotics.
micenet magazine 05/19/2019 19:58
Destination NSW has released a new tourism video for Western Sydney, showcasing key attractions in Parramatta, Penrith, The Hills District, Liverpool, Blacktown, Fairfield, Camden, Campbelltown and Picton. The drawcards featured include sites of natural beauty, historic locations, cultural experiences, fine dining and outdoor adventures. Western Sydney currently delivers $4.5 billion in visitor expenditure for the state.
ACN Newswire 05/19/2019 19:56
Offer Price Set Between HK$1.50 to HK$1.95 per Share, To Raise Gross Proceeds Up to HK$1,528 Million A Leading Biopharmaceutical Company in China, Focusing on the Research, Development and Production of New Drugs and Biosimilar for Cancers and Autoimmune Diseases HONG KONG, May 20, 2019 - (ACN Newswire) - A leading biopharmaceutical company in China - Mabpharm Limited (stock code: 2181), announced on 17th that the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited.

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications